Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > R Matthew Patterson > Profile

R Matthew Patterson

Affiliations

  • at Vor Biopharma Inc. (VOR), 2025-05-23
  • at Homology Medicines Inc. (FIXX), 2023-06-15
  • Director at 5:01 Acquisition Corp. (FVAM), 2020-10-21
  • Chief Executive Officer at Audentes Therapeutics Inc. (BOLD), 2020-01-15
  • Acting Ceo & President at Amicus Therapeutics Inc (FOLD), 2011-04-19
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
BOLD $30.00 14,426 $432,780.00 113,394 2019-11-08 Filing
BOLD $34.53 1,000 $34,525.00 115,368 2019-08-12 Filing
BOLD $34.02 19,000 $646,309.70 116,368 2019-08-12 Filing
BOLD $30.00 4,000 $120,000.00 118,700 2019-02-25 Filing
BOLD $30.00 17,000 $510,000.00 118,700 2019-02-25 Filing